NBTX Nanobiotix
Company Analysis
Latest News
🟢 Nanobiotix is trading 11% up with no clear catalyst identified
Nanobiotix is trading at $28.58, up 10.65%, with no clear company-specific catalyst identified for the October 22 move. - The latest located company news was...
🟢 Nanobiotix is trading 7.12% up — catalyst remains unclear
Nanobiotix is trading at $28.59, up 7.12%, with the catalyst for the October 22 move remaining unclear. - No new company-specific announcement explaining the...
🟢 Nanobiotix is trading 6.24% up in pre-market as biotech ETF XBI rises
Nanobiotix is trading at $27.44, up 6.24% in pre-market, with biotech-sector strength supporting a sector-led explanation. - Biotech ETF XBI is up 3.64%...
🟢 Nanobiotix is trading 11.1% up today amid broader biotech strength
Nanobiotix is trading at $26.82, up 11.1% on October 21, 2026, with broader biotech strength the clearest available context; no company-specific catalyst was...
🟢 Nanobiotix is trading 6.4% up, amid broader biotech-sector strength
Nanobiotix is trading 6.42% up at $25.69 on October 21, with broader biotech-sector strength providing context rather than a clear company-specific...
🟢 Nanobiotix is trading 5% up in pre-market alongside biotech ETF gains
Nanobiotix is trading 5.29% higher at $25.42 in pre-market on October 21, with biotech-sector strength the likeliest context for the move. - XBI gained 3.64%...
🟢 Nanobiotix is trading 11.5% up amid 2.09% biotech-sector gains
Nanobiotix is trading at $23.50, up 11.48%, with broader biotech gains offering a potential tailwind, though no specific cause for the session’s move has been...
🟢 Nanobiotix is trading 5% up today with no confirmed company-specific catalyst
Nanobiotix is trading 5.40% higher at $22.43, with no confirmed company-specific catalyst identified for October 15, 2026. - A market snapshot also reported...
🔴 Nanobiotix is trading 5.7% down amid biotech weakness; no clear catalyst
Nanobiotix is trading 5.7% lower at $22.06 on October 13, 2026, amid biotech weakness, but no clear company-specific catalyst has emerged. - The supplied...
🟢 Nanobiotix is trading 7% up today amid a biotech-sector rally
Nanobiotix is trading at $24.50, up 6.99%, alongside a biotech-sector rally and gains in major U.S. indexes. - No specific company announcement or catalyst was...
🔴 Nanobiotix is trading 5% down today after breaking below watched support
Nanobiotix is trading at $23.30, down 5.34%, amid reported selling pressure and a break below a watched support level. - No new company-specific announcement...
🟢 Nanobiotix is trading 9.67% up in after-hours trading with no clear company-specific catalyst identified
Nanobiotix is trading at $27.00, up 9.67% in after-hours trading; no clear company-specific catalyst was identified. - The latest company release found was an...
🟢 Nanobiotix is trading 6.4% up in pre-market
Nanobiotix is trading 6.4% up in pre-market at $27.40; no clear company-specific catalyst for the October 5 move was identified in available coverage. - The...
🔴 Nanobiotix is trading 5.9% down with no clear catalyst identified
Nanobiotix is trading 5.88% lower at $26.26, with no clear announcement explaining the October 2 move. - The company announced first data from a Phase 1...
🔴 Nanobiotix is trading 10% down
Nanobiotix is trading 10.01% down at $28.04 on October 1, 2026; no clear company-specific announcement explaining the decline surfaced. - Investor-relations...
🔴 Nanobiotix is trading 5% down
Nanobiotix is trading at $29.57, down 5.09%; no clear company-specific announcement explaining the October 1 decline surfaced in the search. - Nanobiotix’s...
🔴 Nanobiotix is trading 5.8% down in pre-market with no clear company-specific catalyst
Nanobiotix is trading 5.8% lower at $31.38 in pre-market, with no clear company-specific catalyst identified. - The company’s latest listed release, dated...
Nanobiotix Q2 2026 Earnings Preview: What Analysts Expect on September 29, 2026
Analysts expect Nanobiotix to report Q2 2026 revenue of $1.73 million and a net loss of $0.29 per share, with the stock currently trading at approximately...
🔴 Nanobiotix is trading 5.63% down in pre-market amid a broader biotechnology selloff
Nanobiotix is trading 5.63% down at $31.57 now, following a broader biotechnology selloff rather than a clearly identified company-specific negative...
🔴 Nanobiotix is trading 10.05% down today amid broader biotech selloff
On September 24, 2026, Nanobiotix is trading at $31.70, down 10.05%, amid a broader biotechnology selloff. - XBI is down 2.04%; elevated Treasury yields and...